Literature DB >> 25516671

Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.

Hee Sun Park1, Young Jun Kim1, Mi Hye Yu1, Won Hyeok Choe1, Sung Il Jung1, Hae Jeong Jeon1.   

Abstract

AIM: To evaluate the feasibility of 3-Tesla magnetic resonance elastography (MRE) for hepatic fibrosis and to compare that with diffusion-weighted imaging (DWI) and gadoxetic acid-enhanced magnetic resonance (MR) imaging.
METHODS: Forty-two patients were included in the study. On MRE, mean stiffness values were measured on the elastograms in kilopascals. The apparent diffusion coefficient (ADC) of the liver was measured using DWI. On gadoxetic acid enhanced MR, the contrast enhancement index (CEI) was calculated as signal intensity (SI)post/SIpre, where SIpost is liver-to-muscle SI ratio on hepatobiliary phase images and SIpre is that on nonenhanced images. Correlation between aspartate aminotransferase to the platelet ratio index (APRI) and three MR parameters was assessed. Each MR parameter was compared between a hepatic fibrosis (HF) group and non-hepatic fibrosis (nHF) group.
RESULTS: Liver stiffness showed strong positive correlation with APRI [Spearman correlation coeffiecient (r) = 0.773, P < 0.0001], while ADC and CEI showed weak or prominent negative correlation (r = -0.28 and -0.321, respectively). In the HF group, only liver stiffness showed strong correlation with APRI (r = 0.731, P < 0.0001). Liver stiffness, ADC, and APRI were significantly different between the HF group and nHF group.
CONCLUSION: MRE at 3-Tesla could be a feasible method for the assessment of hepatic fibrosis.

Entities:  

Keywords:  Diffusion weighted imaging; Gadoxetic acid enhanced magnetic resonance imaging; Hepatic fibrosis; Magnetic resonance elastography; Serum markers

Mesh:

Substances:

Year:  2014        PMID: 25516671      PMCID: PMC4265618          DOI: 10.3748/wjg.v20.i46.17558

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Hepatic fibrosis, stellate cells, and portal hypertension.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2006-08       Impact factor: 6.126

Review 3.  Noninvasive measures of liver fibrosis.

Authors:  Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

4.  Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.

Authors:  Bachir Taouli; Anuj J Tolia; Mariela Losada; James S Babb; Edwin S Chan; Michael A Bannan; Hillel Tobias
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

5.  Magnetic resonance elastography of liver in healthy Asians: normal liver stiffness quantification and reproducibility assessment.

Authors:  Sudhakar K Venkatesh; Gang Wang; Lynette L S Teo; Bertrand W L Ang
Journal:  J Magn Reson Imaging       Date:  2013-10-02       Impact factor: 4.813

6.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

7.  Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

Authors:  J F Cadranel; P Rufat; F Degos
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

8.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 9.  Evaluation of liver fibrosis: a concise review.

Authors:  Nezam H Afdhal; David Nunes
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

10.  Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.

Authors:  Sudhakar Kundapur Venkatesh; Gang Wang; Seng Gee Lim; Aileen Wee
Journal:  Eur Radiol       Date:  2013-08-09       Impact factor: 5.315

View more
  11 in total

Review 1.  General review of magnetic resonance elastography.

Authors:  Gavin Low; Scott A Kruse; David J Lomas
Journal:  World J Radiol       Date:  2016-01-28

Review 2.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 3.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

4.  Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.

Authors:  Thierry Lefebvre; Claire Wartelle-Bladou; Philip Wong; Giada Sebastiani; Jeanne-Marie Giard; Hélène Castel; Jessica Murphy-Lavallée; Damien Olivié; André Ilinca; Marie-Pierre Sylvestre; Guillaume Gilbert; Zu-Hua Gao; Bich N Nguyen; Guy Cloutier; An Tang
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

5.  Comparison of spin-echo echoplanar imaging and gradient recalled echo-based MR elastography at 3 Tesla with and without gadoxetic acid administration.

Authors:  Yong Seek Kim; Ji Soo Song; Stephan Kannengiesser; Seung Young Seo
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 6.  Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Da-Wu Zeng; Jing Dong; Yu-Rui Liu; Jia-Ji Jiang; Yue-Yong Zhu
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

7.  Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.

Authors:  Da-Wu Zeng; Jing Dong; Jia-Ji Jiang; Yue-Yong Zhu; Yu-Rui Liu
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

Review 8.  Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.

Authors:  Cher Heng Tan; Sudhakar Kundapur Venkatesh
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

9.  Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B.

Authors:  Tiffany P Hennedige; Gang Wang; Fiona P Leung; Hind S Alsaif; Lynette Ls Teo; Seng Gee Lim; Aileen Wee; Sudhakar K Venkatesh
Journal:  Gut Liver       Date:  2017-05-15       Impact factor: 4.519

Review 10.  Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.

Authors:  Anuradha Shenoy-Bhangle; Vinit Baliyan; Hamed Kordbacheh; Alexander R Guimaraes; Avinash Kambadakone
Journal:  World J Hepatol       Date:  2017-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.